ATA341575A - Verfahren zur herstellung von neuen morpholinderivaten und von ihren saureadditionssalzen - Google Patents

Verfahren zur herstellung von neuen morpholinderivaten und von ihren saureadditionssalzen

Info

Publication number
ATA341575A
ATA341575A AT341575A AT341575A ATA341575A AT A341575 A ATA341575 A AT A341575A AT 341575 A AT341575 A AT 341575A AT 341575 A AT341575 A AT 341575A AT A341575 A ATA341575 A AT A341575A
Authority
AT
Austria
Prior art keywords
production
acid addition
addition salts
morpholine derivatives
new morpholine
Prior art date
Application number
AT341575A
Other languages
English (en)
Other versions
AT344188B (de
Inventor
Bernard J Mcloughlin
Allen J Guildford
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Priority to AT266977A priority Critical patent/AT344715B/de
Priority to AT266877A priority patent/AT344714B/de
Publication of ATA341575A publication Critical patent/ATA341575A/de
Application granted granted Critical
Publication of AT344188B publication Critical patent/AT344188B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/04Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/6533Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT341575A 1974-05-07 1975-05-05 Verfahren zur herstellung von neuen morpholinderivaten und von ihren saeureadditionssalzen AT344188B (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AT266977A AT344715B (de) 1974-05-07 1977-04-15 Verfahren zur herstellung eines neuen morpholinderivates und von dessen saeureadditionssalzen
AT266877A AT344714B (de) 1974-05-07 1977-04-15 Verfahren zur herstellung von neuen morpholinderivaten und von ihren saeureadditionssalzen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2001374A GB1452701A (en) 1974-05-07 1974-05-07 Morpholine derivatives
JP2495676A JPS52139074A (en) 1974-05-07 1976-03-08 Morpholine derivative and mental version drug composition containing same

Publications (2)

Publication Number Publication Date
ATA341575A true ATA341575A (de) 1977-11-15
AT344188B AT344188B (de) 1978-07-10

Family

ID=26254367

Family Applications (1)

Application Number Title Priority Date Filing Date
AT341575A AT344188B (de) 1974-05-07 1975-05-05 Verfahren zur herstellung von neuen morpholinderivaten und von ihren saeureadditionssalzen

Country Status (20)

Country Link
US (1) US4010266A (de)
JP (2) JPS50154273A (de)
AR (1) AR209436A1 (de)
AT (1) AT344188B (de)
BE (1) BE828822A (de)
CA (1) CA1067075A (de)
CH (2) CH610894A5 (de)
DD (1) DD121641A5 (de)
DE (1) DE2519101A1 (de)
DK (1) DK198675A (de)
FI (1) FI751344A (de)
FR (1) FR2269953B1 (de)
GB (1) GB1452701A (de)
HK (1) HK5580A (de)
IN (1) IN141021B (de)
KE (1) KE3021A (de)
LU (1) LU72408A1 (de)
NL (1) NL7505140A (de)
SE (1) SE425312B (de)
ZA (1) ZA752388B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4088814A (en) * 1974-05-07 1978-05-09 Imperial Chemical Industries Limited Morpholine derivatives
JPS5266991U (de) * 1975-11-13 1977-05-18
AU508678B2 (en) * 1976-07-14 1980-03-27 Imperial Chemical Industries Limited Anorexiants
IE50355B1 (en) * 1979-10-20 1986-04-02 Wyeth John & Brother Ltd Morpholine derivatives
JPH07503461A (ja) * 1992-01-28 1995-04-13 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー カルシウムチャンネル拮抗薬としての化合物
US6048859A (en) * 1992-06-29 2000-04-11 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
US5637699A (en) * 1992-06-29 1997-06-10 Merck & Co., Inc. Process for preparing morpholine tachykinin receptor antagonists
US5719147A (en) * 1992-06-29 1998-02-17 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
IL112778A0 (en) * 1994-03-04 1995-05-26 Merck & Co Inc Substituted heterocycles, their preparation and pharmaceutical compositions containing them
WO1998007710A1 (en) * 1996-08-23 1998-02-26 Neurosearch A/S Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine d4 receptor antagonists
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
AU2001290873B2 (en) 2000-09-11 2006-07-27 Sepracor Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2255077A (en) * 1938-03-21 1941-09-09 Du Pont Film Mfg Corp Filter dyes for color photography

Also Published As

Publication number Publication date
US4010266A (en) 1977-03-01
CA1067075A (en) 1979-11-27
AT344188B (de) 1978-07-10
SE425312B (sv) 1982-09-20
FR2269953B1 (de) 1978-10-06
AU8021575A (en) 1976-10-21
SE7505237L (sv) 1975-11-10
HK5580A (en) 1980-02-29
CH634569A5 (de) 1983-02-15
DK198675A (da) 1975-11-08
LU72408A1 (de) 1976-11-11
GB1452701A (en) 1976-10-13
JPS50154273A (de) 1975-12-12
FR2269953A1 (de) 1975-12-05
JPS52139074A (en) 1977-11-19
ZA752388B (en) 1976-03-31
AR209436A1 (es) 1977-04-29
FI751344A (de) 1975-11-08
IN141021B (de) 1977-01-08
NL7505140A (nl) 1975-11-11
CH610894A5 (de) 1979-05-15
DD121641A5 (de) 1976-08-12
KE3021A (en) 1980-03-14
BE828822A (fr) 1975-11-07
DE2519101A1 (de) 1975-11-20

Similar Documents

Publication Publication Date Title
AT336000B (de) Verfahren zur herstellung von neuen 3-phenoxy-3-phenylpropylaminen und deren saureadditionssalzen
AT343660B (de) Verfahren zur herstellung von neuen bispidinderivaten und ihren salzen
AT335420B (de) Verfahren zur herstellung von neuen n-cycloalkyl-benzylaminen und deren saureadditionssalzen
AT345833B (de) Verfahren zur herstellung von neuen benzimidazolinon-derivaten und ihren saeure- additionssalzen
ATA341575A (de) Verfahren zur herstellung von neuen morpholinderivaten und von ihren saureadditionssalzen
ATA612476A (de) Verfahren zur herstellung von neuen phenoxyal- kylcarbonsaeurederivaten und ihren salzen
AT340417B (de) Verfahren zur herstellung von neuen xanthenderivaten und von deren saureadditionssalzen
AT332426B (de) Verfahren zur herstellung von neuen adenin-derivaten und ihren saureadditionssalzen
AT349004B (de) Verfahren zur herstellung von neuen 4- hydroxyindol-derivaten und ihren salzen
ATA26875A (de) Verfahren zur herstellung von neuen amidoxim-derivaten und ihren saureadditionssalzen
ATA404674A (de) Verfahren zur herstellung von neuen piperidinoalkanon-derivaten und ihren saureadditionssalzen
ATA46475A (de) Verfahren zur herstellung von neuen phentiazinderivaten und von ihren saureadditionssalzen
ATA307175A (de) Verfahren zur herstellung von neuen prostansaeurederivaten und von ihren salzen
ATA606175A (de) Verfahren zur herstellung von neuen prostansaeurederivaten und von ihren salzen
AT347943B (de) Verfahren zur herstellung von neuen xanthensaeure-derivaten und ihren salzen
ATA224875A (de) Verfahren zur herstellung von neuen indolobenzazepinen und deren saureadditionssalzen
AT342594B (de) Verfahren zur herstellung von neuen n- (p-fluorbenzoylpropyl) -4-piperidylamiden und ihren saureadditionssalzen
ATA266877A (de) Verfahren zur herstellung von neuen morpholinderivaten und von ihren saureadditionssalzen
ATA167476A (de) Verfahren zur herstellung von neuen morpholinderivaten und ihren saureadditionssalzen
ATA418976A (de) Verfahren zur herstellung von neuen tetrahydropyridinderivaten und ihren saureadditionssalzen
ATA475973A (de) Verfahren zur herstellung von neuen piperazinderivaten und ihren saureadditionssalzen
ATA882176A (de) Verfahren zur herstellung von neuen thienotriazolodiazepin-derivaten und ihren saureadditionssalzen
ATA467278A (de) Verfahren zur herstellung von neuen 2-(3-c3-c4- verzweigt-alkylamino-2-hydroxy- propoxy)-3-cyanpyridinen und ihren saeure- additionssalzen
AT340416B (de) Verfahren zur herstellung von neuen thiazolidion-essigsaure-derivaten und ihren salzen
ATA753676A (de) Verfahren zur herstellung von neuen xanthenderivaten und von deren saureadditionssalzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee